Two bispecific antibodies have been approved for fourth line treatment of multiple myeloma in Scotland, it has been announced.
The charity Myeloma UK welcomed the news, saying it was the first time in seven years the Scottish Medicines Consortium...
1 year ago
Blood cancer patients treated with CAR T-cell therapy have the same risk of second primary cancers as patients treated in other ways, according to a new study.
The US researchers say the findings may help reassure patients who are worried about th...
1 year ago
